Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin (Q48046708)
Jump to navigation
Jump to search
scientific article published in August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin |
scientific article published in August 2016 |
Statements
1 reference
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin (English)
1 reference
Faiez Zannad
1 reference
Christopher P Cannon
1 reference
Richard M Bergenstal
1 reference
Steven E Nissen
1 reference
EXAMINE Investigators
1 reference
Stuart Kupfer
1 reference
William B White
1 reference
Craig A Wilson
1 reference
George L Bakris
1 reference
William C Cushman
1 reference
Simon K Heller
1 reference
Cyrus R Mehta
1 reference
1 August 2016
1 reference
1 reference
68
1 reference
3
1 reference
606-613
1 reference